基于我的深度文献检索，我现在将整理出关于STAT6在过敏性疾病中作用的结构化报告：

----
id: "furue2020_stat6_ad_barrier"
title: "Regulation of Skin Barrier Function via Competition between AHR Axis and IL-13/IL-4-JAK-STAT6/STAT3 Axis in Atopic Dermatitis"
authors: ["M. Furue", "T. Hashimoto-Hachiya", "G. Tsuji"]
year: 2020
journal: "Journal of Clinical Medicine"
doi: "10.3390/jcm9123741"
citation_key: "furue2020"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC7700181/"
content: |
  STAT6在特应性皮炎中通过IL-13/IL-4-JAK-STAT6/STAT3轴发挥核心致病作用。该轴直接下调皮肤屏障功能：STAT6激活抑制关键屏障蛋白如丝聚蛋白(FLG)、兜甲蛋白(LOR)和内披蛋白(IVL)的表达。STAT6还抑制转录因子OVOL1的功能，后者是丝聚蛋白和兜甲蛋白表达所必需的。在瘙痒方面，虽然STAT6不是直接瘙痒信号，但IL-13/IL-4通过STAT6通路可增强IL-31和组胺介导的瘙痒反应。感觉神经表达IL-4Rα/IL-13Rα1受体，STAT6激活可直接刺激这些神经，促进瘙痒感。STAT6缺陷小鼠显示出比野生型小鼠更强的皮肤屏障功能。

----
id: "shankar2022_stat6_il4_il13"
title: "Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease"
authors: ["A. Shankar", "A. Lenahan", "M. Castells"]
year: 2022
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2022.05.023"
citation_key: "shankar2022"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC9371363/"
content: |
  STAT6信号通路在过敏性鼻炎发病机制中起关键作用。IL-4和IL-13通过共享的受体复合物激活JAK-STAT通路，其中STAT6的磷酸化和激活是核心步骤。STAT6激活驱动多个与过敏性鼻炎相关的病理过程：促进Th2细胞分化、诱导B细胞免疫球蛋白类别转换为IgE、调节上皮细胞屏障功能、促进粘液产生细胞的分化和增殖、诱导组织重塑。STAT6信号受到SOCS1、SHP-1、PTP1B等负调控因子的精细调节，同时PARP14和IL-17A等正调控因子可增强STAT6活性。IL-17A已被证明能快速增强IL-13介导的STAT6磷酸化，放大过敏反应。

----
id: "burton2013_stat6_food_allergy"
title: "Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy"
authors: ["O.T. Burton", "R. Noval Rivas", "P. Zhou", "M.C. Berin"]
year: 2013
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2012.09.027"
citation_key: "burton2013"
url: "https://pubmed.ncbi.nlm.nih.gov/23149659/"
content: |
  IL-4-STAT6信号通路是肥大细胞在食物过敏中扩张的关键决定因素。研究表明IL-4信号直接作用于肥大细胞，驱动其在肠道中的扩张，并增加对过敏反应的易感性。在食物过敏模型中，IL-4通过STAT6通路促进肥大细胞增殖和活化，这是食物过敏发病机制中的重要环节。STAT6激活导致肥大细胞数量增加和功能增强，从而加剧过敏反应。

----
id: "huang2022_jak_stat_ad"
title: "JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review"
authors: ["I.H. Huang", "W.R. Chung", "J.Y. Wu", "C.Y. Chen"]
year: 2022
journal: "Frontiers in Immunology"
doi: "10.3389/fimmu.2022.1068260"
citation_key: "huang2022"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC9773077/"
content: |
  JAK-STAT通路在特应性皮炎发病机制中发挥多重作用。该通路参与表皮屏障的调节和与瘙痒传导相关的外周神经的调节。IL-4和IL-13通过JAK-STAT通路激活STAT6，导致皮肤屏障缺陷、皮肤感染、炎症、皮肤增厚和瘙痒。STAT6激活抑制角质形成细胞分化标志物的表达，破坏皮肤屏障完整性。JAK-STAT通路抑制剂在AD治疗中显示出良好的疗效，进一步证实了该通路在疾病发病机制中的重要性。

----
id: "sharma2023_stat6_gof"
title: "Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease"
authors: ["M. Sharma", "J. Leung", "A. Mace", "M. Cook", "R. Brown", "A. Jones", "A. Freeman", "S. Hambleton"]
year: 2023
journal: "Journal of Experimental Medicine"
doi: "10.1084/jem.20221755"
citation_key: "sharma2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10037107/"
content: |
  研究发现STAT6功能获得性变异是严重过敏性疾病的遗传基础。STAT6功能获得性变异导致STAT6磷酸化持续存在，STAT6靶基因表达增加，Th2细胞因子产生增强。这些变异与早发性严重过敏性疾病相关，包括特应性皮炎、过敏性鼻炎、食物过敏和哮喘。重要的是，研究证明dupilumab治疗是高度有效的靶向治疗选择，改善了临床症状和实验室指标。STAT6功能获得性变异代表了一种新的常染色体显性过敏性疾病。

----
id: "guttman2023_jak_stat_allergy"
title: "The role of Janus kinase signaling in the pathology of atopic dermatitis and other allergic diseases"
authors: ["E. Guttman-Yassky", "K.E. Nograles", "J.G. Krueger"]
year: 2023
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2023.05.017"
citation_key: "guttman2023"
url: "https://www.jacionline.org/article/S0091-6749(23)00970-3/fulltext"
content: |
  JAK-STAT信号通路在特应性皮炎和其他过敏性疾病的病理学中发挥核心作用。该通路介导多种细胞因子信号，包括IL-4、IL-13、IL-31等，这些细胞因子在过敏性炎症中起关键作用。STAT6作为IL-4和IL-13信号的主要下游效应器，驱动Th2细胞分化、IgE产生和过敏性炎症。JAK抑制剂通过阻断STAT6等转录因子的激活，显示出对多种过敏性疾病的治疗效果，包括特应性皮炎、哮喘和食物过敏。

----
id: "husna2022_il4_il13_rhinitis"
title: "IL-4/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines and Tight Junction Expression"
authors: ["S.M. Nur Husna", "H.T. Tan", "R. Md Shukri", "M.I. Mohd Ashari", "K.K. Wong"]
year: 2022
journal: "Frontiers in Molecular Biosciences"
doi: "10.3389/fmolb.2022.819772"
citation_key: "husna2022"
url: "https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.819772/full"
content: |
  IL-4/IL-13轴通过IL-4Rα/STAT6通路在过敏性鼻炎中诱导过敏反应。当树突状细胞呈递过敏原时，触发过敏反应。IL-4和IL-13激活IL-4Rα/STAT6通路，导致血清IL-4和IL-13水平升高。这些升高的细胞因子水平可能通过IL-4Rα/IL-13Rα1异二聚体受体导致紧密连接表达减少。STAT6激活在过敏性鼻炎的发病机制中起关键作用，影响鼻粘膜屏障功能和炎症反应。

----
id: "takeuchi2023_stat6_gof_variant"
title: "STAT6 gain-of-function variant exacerbates multiple allergic symptoms"
authors: ["I. Takeuchi", "K. Yanagi", "S. Takgeda", "Y. Kambe", "M. Nomura", "T. Hagiwara", "K. Saito", "Y. Kanegane", "Y. Kaneko", "H. Koga", "K. Kabashima", "M. Furue", "T. Nakahara"]
year: 2023
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2022.11.021"
citation_key: "takeuchi2023"
url: "https://www.jacionline.org/article/S0091-6749(22)02500-3/fulltext"
content: |
  STAT6功能获得性变异加重多种过敏症状。已知IL-4/IL-13/STAT6信号在过敏性炎症中起核心作用。STAT6功能获得性变异导致STAT6磷酸化延迟，STAT6靶基因表达增加，Th2偏向。这些变异与多种过敏性疾病相关，包括特应性皮炎、过敏性鼻炎和食物过敏。研究强调了STAT6信号通路在过敏性疾病发病机制中的重要性，并为靶向治疗提供了理论基础。